Home›Search›Investigational New Drugs

Investigational New Drugs

Springer · United States

ISSN0167-6997eISSN1573-0646

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

Total50

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.074

H-Index

115

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.732

Total Works

3,989

Total Citations

106,714

2yr Mean Citedness

3.21

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope

Investigational New Drugs is a forum for rapid dissemination of information on new anticancer agents. The journal publishes original articles dealing with anticancer drug development. It provides the fastest possible publication of new discoveries for scientists developing anticancer agents. The journal also publishes proceedings of special workshops and symposia on anticancer drug development. It is open to publishing clinical trials with negative results if they contribute to the understanding of investigational agents.

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 25% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published—

Annual Volume~ 89 articles / year

StatusActive

Total Publications3,989

Publisher OrgSpringer Science+Business Media

Visit Journal Website

Submission Info

Publishing ModelHybrid

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

⚡ Hybrid journal — subscription model available.

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Springer

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

0167-6997 / 1573-0646

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

PharmacologyQ1

Pharmacology (medical)Q1

OncologyQ2

Subject Classification

Web of Science Categories

OncologyPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Oncology

Research Topics (OpenAlex)

Cancer Treatment and PharmacologyCancer therapeutics and mechanismsLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesLung Cancer Research Studies